These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1818788)

  • 1. Chronotherapy in coronary heart disease: comparison of two nitrate treatments.
    Wortmann A; Bachmann K
    Chronobiol Int; 1991; 8(5):399-408. PubMed ID: 1818788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation of cardiac performance in coronary heart disease.
    Wortmann A; Bachmann K
    Chronobiol Int; 1990; 7(4):317-9. PubMed ID: 2085872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian investigation of interval therapy with isosorbide dinitrate in coronary heart disease.
    Wortmann A; Bachmann K; Meinhold M
    Eur Heart J; 1988 Jan; 9 Suppl A():119-24. PubMed ID: 3409908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and circumvention of nitrate tolerance applying different dosage intervals.
    Silber S; Vogler AC; Krause KH; Vogel M; Theisen K
    Am J Med; 1987 Nov; 83(5):860-70. PubMed ID: 3674093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
    Wiechmann HW; Schuster P; Trieb G
    Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
    Wiechmann HW; Schuster P; Trieb G
    Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic and electrocardiographic prolonged nitrate effect during frequency load in coronary disease].
    Wolf R; Beck OA; Guhl E; Hochrein H
    Z Kardiol; 1976 May; 65(5):435-44. PubMed ID: 820104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic study of the development of tolerance in intravenous nitrate therapy].
    Unverdorben M; Pfeiffer F; Kunkel B; Bachmann K
    Z Kardiol; 1989; 78 Suppl 2():88-94; discussion 115-7. PubMed ID: 2686259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isosorbide-5-mononitrate in silent ischemia].
    Pichler M; Brandt D; Teubl H; Dorda W
    Wien Klin Wochenschr; 1995; 107(13):390-5. PubMed ID: 7638969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic, anti-ischemic, and neurohumoral effects of slow-release isosorbide-5-mononitrate in patients with coronary artery disease after short- and long-term therapy.
    Mitrovic V; Gessner C; Hain P; Müller KD; Schlepper M
    Clin Cardiol; 1991 Mar; 14(3):209-18. PubMed ID: 1672843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
    Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
    J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
    Vogler AC; Silber S; Spiegelsberger F; Theisen K
    Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G; Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease.
    Kasparian H; Wiener L; Duca PR; Gottlieb RS; Brest AN
    Am Heart J; 1975 Jul; 90(1):68-74. PubMed ID: 1094819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
    Jansen W; Meyer L; Tauchert M
    Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.
    Silber S; Vogler AC; Krause KH; Theisen K
    Drugs; 1987; 33 Suppl 4():69-79. PubMed ID: 3622317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.